Anemoside B4 Inhibits Vascular Smooth Muscle Cell Proliferation, Migration, and Neointimal Hyperplasia.
Anemoside B4 Inhibits Vascular Smooth Muscle Cell Proliferation, Migration, and Neointimal Hyperplasia.
复制标题
DOI:
10.3389/fcvm.2022.907490
复制
发表时间:
2022
影响因子:
3.6
通讯作者:
Yu, Jun
中科院分区:
文献类型:
--
作者:
Shan, Dan;Qu, Ping;Zhong, Chao;He, Luling;Zhang, Qingshan;Zhong, Guoyue;Hu, Wenhui;Feng, Yulin;Yang, Shilin;Yang, Xiao-feng;Yu, Jun
Vascular smooth muscle cell (VSMC) phenotypic transformation, proliferation, and migration play a pivotal role in developing neointimal hyperplasia after vascular injury, including percutaneous transluminal angioplasty and other cardiovascular interventions. Anemoside B4 (B4) is a unique saponin identified from the Pulsatilla chinensis (Bge.) Regel, which has known anti-inflammatory activities. However, its role in modulating VSMC functions and neointima formation has not been evaluated. Herein, we demonstrate that B4 administration had a potent therapeutic effect in reducing neointima formation in a preclinical mouse femoral artery endothelium denudation model. Bromodeoxyuridine incorporation study showed that B4 attenuated neointimal VSMC proliferation in vivo. Consistent with the in vivo findings, B4 attenuated PDGF-BB-induced mouse VSMC proliferation and migration in vitro. Moreover, quantitative RT-PCR and Western blot analysis demonstrated that B4 suppressed PDGF-BB-induced reduction of SM22α, SMA, and Calponin, suggesting that B4 inhibited the transformation of VSMCs from contractile to the synthetic phenotype. Mechanistically, our data showed B4 dose-dependently inhibited the activation of the phosphatidylinositol 3-kinase (PI3K)/AKT and p38 mitogen-activated protein kinase MAPK signaling pathways. Subsequently, we determined that B4 attenuated VSMC proliferation and migration in a p38 MAPK and AKT dependent manner using pharmacological inhibitors. Taken together, this study identified, for the first time, Anemoside B4 as a potential therapeutic agent in regulating VSMC plasticity and combating restenosis after the vascular intervention.
登录
查看更多内容
影响因子:
11.4
作者:
Lu QB;Wan MY;Wang PY;Zhang CX;Xu DY;Liao X;Sun HJ
通讯作者:
Sun HJ
影响因子:
5.6
作者:
BLANK, RS;OWENS, GK
通讯作者:
OWENS, GK
影响因子:
4.8
作者:
Liu, Y;Sinha, S;Owens, G
通讯作者:
Owens, G
影响因子:
1.8
作者:
Guo, Xiaozhen;Xie, Yang;Huang, Chenggang
通讯作者:
Huang, Chenggang
影响因子:
3.8
作者:
Liu, Ming;Zhao, Xingzeng;Lin, Xiukun
通讯作者:
Lin, Xiukun